Interruption in enzyme replacement therapy for Gaucher disease

被引：6

作者：

Weinreb, NJ ^{[1
]}

机构：

[1] Univ Gaucher Res Fdn, Int Cooperat Gaucher Grp, Hollywood, FL 33019 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2001年 / 113卷 / 04期

关键词：

Gaucher disease; liver volume; enzyme replacement therapy;

D O I：

10.1046/j.1365-2141.2001.02821-11.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1087 / 1088

页数：2

共 5 条

[1] THERAPEUTIC RESPONSE TO INTRAVENOUS INFUSIONS OF GLUCOCEREBROSIDASE IN A PATIENT WITH GAUCHER DISEASE [J].

BARTON, NW ;

FURBISH, FS ;

MURRAY, GJ ;

GARFIELD, M ;

BRADY, RO .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1913-1916

[2] The Gaucher registry -: Demographics and disease characteristics of 1698 patients with Gaucher disease [J].

Charrow, J ;

Andersson, HC ;

Kaplan, P ;

Kolodny, EH ;

Mistry, P ;

Pastores, G ;

Rosenbloom, BE ;

Scott, CR ;

Wappner, RS ;

Weinreb, NJ ;

Zimran, A .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) :2835-2843

[3] Withdrawal of enzyme replacement therapy in Gaucher's disease [J].

Elstein, D ;

Abrahamov, A ;

Hadas-Halpern, I ;

Zimran, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (02) :488-492

[4] Enzyme therapy for Gaucher disease: the first 5 years [J].

Grabowski, GA ;

Leslie, N ;

Wenstrup, R .

BLOOD REVIEWS, 1998, 12 (02) :115-133

[5]

Weinreb N, 1999, BLOOD, V94, p210A

← 1 →